On August 18, HymonBio celebrated its 9th anniversary amid great anticipation and attention, and successfully held a thrilling new product launch. Afterwards, academic reports and roundtable forums were held. This event was not only a gorgeous display of the company’s scientific research achievements, but also an academic feast that led the industry.
Academic Reports
The excitement of the new product launch has not yet dissipated. Professor Wang Hualiang, Chairman of the Experimental Medicine Branch of the National Health Industry Enterprise Management Association and President of the Shanghai Institute of Experimental Medicine, gave everyone a wonderful academic report entitled “Progress in Tumor Screening Technology”.
Professor Wang Hualiang emphasized in his report that in today’s era of rapid development of biotechnology, tumor screening technology is undergoing unprecedented changes. PCR technology is like a sword that is constantly sharpened and improved day by day, making the detection of tumor-related genes more comprehensive and accurate. This breakthrough has built a solid bridge for the prevention and treatment of tumors and provided strong technical support. This report is like a beacon, not only deeply analyzing the latest achievements of tumor screening technology, but also looking forward to its future development direction from a far-sighted perspective. It is worth mentioning that Professor Wang Hualiang highly praised HymonBio’s new products and fully recognized its broad development prospects.
Roundtable Forum
As the conference continues, many experts, scholars and enterprise representatives in the industry also generously contributed their wisdom and insights. They gathered together to carry out heated and in-depth discussions and exchanges around the profound topic of “China’s innovative road for biomedicine – White Crane Sword”. The collision of ideas is like a bright spark, illuminating the way forward for China’s biomedicine industry.
HymonBio’s 9th anniversary and the launch of new pan-cancer early screening products are undoubtedly a new starting point. Standing at this new starting point, let us hold high expectations and witness together the new chapters in the years to come!
Post time: Aug-18-2024